Loading
A phase 3 trial of Ibandronic acid in Metastatic cancer and Prostate cancer, run by Cancer Research UK, completed.
Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain is a phase 3 interventional study registered as NCT00082927 by Cancer Research UK, with 580 participants recorded, started 2003-04. Interventions recorded: ibandronate sodium. Conditions recorded: Metastatic Cancer, Pain, Prostate Cancer.
Linked to the drug Ibandronic acid because the registry names it among its interventions and Metastatic cancer and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Ibandronic acid, Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Ibandronic acid and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/